FDA propose drug label changes for use in pregnancy

Author：

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1205, 2008-01, pp. : 1-1

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

FDA turning a blind eye to off-label drug use?

Inpharma, Vol. 1, Iss. 1634, 2008-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Coverage Policy and Use Beyond the FDA-Approved Label

By McGivney William T.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 4, Iss. 2, 2006-02 ,pp. : 99-101

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Analgesics in Pregnancy: An Update on Use, Safety and Pharmacokinetic Changes in Drug Disposition

Current Pharmaceutical Design, Vol. 23, Iss. 40, 2018-02 ,pp. : 6098-6114

Bentham Science Publishers

Access to resources Recommend Favorite

FDA recommends against off-label sildenafil use in children

Reactions Weekly, Vol. 1, Iss. 1418, 2012-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Unlicensed and Off-Label Drug Use: Issues and Recommendations

By Conroy S.

Pediatric Drugs, Vol. 4, Iss. 6, 2002-01 ,pp. : 353-359

Adis International

Access to resources Recommend Favorite